Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone

Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine

(2020) Trine Frederiksen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016

(2019) Anitha Saravanakumar et al.   CLINICAL PHARMACOKINETICS

Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population

(2019) Ha Hai Nguyen et al.   MEDICINE

PharmVar GeneReview: CYP2D6

(2019) Charity Nofziger et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Interrogation of CYP2D6 structural variant alleles improves the correlation between CYP2D6 genotype and CYP2D6‐mediated metabolic activity

(2019) Rachel Dalton et al.   CTS-Clinical and Translational Science

Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

(2019) Kelly E. Caudle et al.   CTS-Clinical and Translational Science

CYP2D6 genotype analysis of a Thai population: platform comparison

(2018) Monpat Chamnanphon et al.   PHARMACOGENOMICS

Frequency of CYP2D6 Alleles Including Structural Variants in the United States

(2018) Andria L. Del Tredici et al.   Frontiers in Pharmacology

CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes

(2018) Ji-Young Byeon et al.   ARCHIVES OF PHARMACAL RESEARCH

Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection

(2018) Wanqiong Qiao et al.   PHARMACOGENOMICS

Impact of CYP2D6 Polymorphism on Steady-State Plasma Levels of Risperidone and 9-Hydroxyrisperidone in Thai Children and Adolescents with Autism Spectrum Disorder

(2017) Natchaya Vanwong et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

CYP2D6 Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of CYP2D6∗10 on Interindividual Variation in a Chinese Population

(2017) Rui Chen et al.   Frontiers in Pharmacology

Practical interpretation of CYP2D6 haplotypes: Comparison and integration of automated and expert calling

(2016) Gualberto Ruaño et al.   CLINICA CHIMICA ACTA

Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD

(2016) JT Brown et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels

(2016) Natchaya Vanwong et al.   Drug Metabolism and Pharmacokinetics

Erratum to: Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol

(2016) Lisbeth Patteet et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Prediction of CYP2D6 phenotype from genotype across world populations

(2016) Andrea Gaedigk et al.   GENETICS IN MEDICINE

Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders

(2016) Natchaya Vanwong et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients

(2014) Buster Mannheimer et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy

(2012) Elaine Lyon et al.   GENETICS IN MEDICINE

The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone

(2010) Nikolina Jovanović et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effect of CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the Pharmacokinetics of Risperidone and Its Active Moiety

(2010) Qian Xiang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effects of CYP2D6 and CYP3A5 Genotypes on the Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Korean Schizophrenic Patients

(2009) Rhee-Hun Kang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY